ClearPoint Neuro, Inc. (CLPT) Misses Q2 EPS by 9c

ClearPoint Neuro, Inc. (NASDAQ: CLPT) reported Q2 EPS of ($0.38), $0.09 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $10.9 million versus the consensus estimate of $12.73 million.

For earnings history and earnings-related data on ClearPoint Neuro, Inc. (CLPT) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
• JPMorgan Starts Bytes Technology Group PLC (BYIT:LN) at Underweight